NEW Secondary Antibodies For VHH Discovery
Secondary Antibodies For VHH Discovery
JIR presents Anti-Alpaca IgG, Subclass and VHH domain secondary antibodies to optimize VHH (single domain) antibody development and application.
Pathway to recombinant VHH antibody development
 |
The development of high affinity VHH antibodies follows the well-established pathway shown. JIR Anti-Alpaca antibodies can be utilized at specific stages to expedite and enhance the development of high affinity VHH antibodies.
|
Monitor IgG 2+3 subclass titer to ideally time PBMC harvest
| Use JIR Anti-Alpaca IgG, subclasses 2+3 to time PBMC harvest for VHH library construction. The VHH domain is located on these subclasses only. Subclass 2+3 response may mature differently from total IgG, and monitoring serum conversion of these antibodies can inform the decision to harvest PBMCs.
Timing PBMC harvest based on total IgG titer might suggest a collection point at 150 days, but the IgG 2+3 response was not maximal until after 300 days post immunization. This ELISA data shows the antibody subclass repertoire in response to the immunogen over time. Antiserum was used to detect the coated immunogen, and peroxidase-conjugated secondary antibodies were used to compare total IgG to IgG subclasses 2+3. |
 |
Anti-Camelid Secondary Antibodies
Enhance detection of VHH antibodies using
Goat Anti-Alpaca IgG, VHH domain
| Anti-Alpaca IgG, VHH domain antibodies show amplified signal compared to an anti-tag antibody. Polyclonal antibodies that broadly recognize many epitopes on VHH deliver additional signaling molecules (e.g. fluorophores or enzymes) vs. antibodies narrowly focused on small peptide sequences. In this figure, a His6 tagged recombinant VHH was detected by western blot using Goat Anti-VHH domain antibody or an anti-His6 antibody. |
 |
||
 |
Test for VHH expression and binding activity with greater confidence
Screening VHH-expressing clones for solubility and binding activity is commonly done by ELISA. Significant signal can be obtained even at low VHH concentrations. In this panel, VHH was titrated across its coated immunogen and detected with Peroxidase conjugated Goat Anti-Alpaca VHH domain antibody. |
||
| AffiniPure™ Secondary Antibodies | Product Code |
| Goat Anti-Alpaca IgG (H+L) | 128-005-003 |
| Goat Anti-Alpaca IgG (H+L) (min X Bov, Hu, Ms, Rb, Rat Sr Prot) | 128-005-160 |
| Goat Anti-Alpaca IgG, subclasses 2+3 specific (min X Bov, Hu, Ms, Rb, Rat Sr Prot) | 128-005-229 |
| Goat Anti-Alpaca IgG, VHH domain (min X Bov Sr Prot) | 128-005-232 |
| Goat Anti-Alpaca IgG, VHH domain (min X Bov, Hu, Ms, Rb, Rat Sr Prot) | 128-005-230 |
| *These antibodies react primarily with the Fc region, and are not recommended for detection of VHH antibodies. | |
Available in a wide range of conjugate options
| Horseradish Peroxidase | DyLight™ 405 | Cy™ 3 | Alexa Fluor® 594 |
| Alkaline Phosphatase | Alexa Fluor® 488 | R-Phycoerythrin (R-PE) | Alexa Fluor® 647 |
| Biotin-SP | Fluorescein (FITC) | Rhodamine Red™-X | Cy™ 5 |
AffiniPure™ Antibodies is a trademark of Jackson ImmunoResearch Laboratories, Inc. DyLight™ fluorescent dyes is a trademark of Thermo Fisher Scientific. Cy™ is a registered trademark of GE Healthcare. Rhodamine Red™-X is a trademark of Invitrogen. Alexa Fluor® is a trademark of Life Technologies Corp.
Your first choice for scientific solutions
Find out more
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations